Alfresa Holdings Corporation (2784.T)

JPY 2021.5

(-0.71%)

Market Cap (In JPY)

372.71 Billion

Revenue (In JPY)

2858.5 Billion

Net Income (In JPY)

29.55 Billion

Avg. Volume

473.86 Thousand

Currency
JPY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1929.0-2551.0
PE
10.98
EPS
184.05
Beta Value
-0.001
ISIN
JP3126340003
CUSIP
-
CIK
-
Shares
184374106.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Distribution
CEO
Mr. Ryuji Arakawa
Employee Count
-
Website
https://www.alfresa.com
Ipo Date
2005-09-29
Details
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.